Hide Board Information

Show Board Information

Upexi, Inc. UPXI

Board Mod: Add me as mod

Asst Mods:

Last Post: 10/17/2024 11:57:19 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 1

Upexi, Inc. (NASDAQ: UPXI) Stock Message Board

1. UPXI Company Profile

    

2. UPXI Time & Sales

    

3. UPXI Recent News

    

4. UPXI Filings

    

5. UPXI Financials

    

6. UPXI Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

4	$UPXI Hod4.32 PMH11.02 Sits @ 15% v2,79M @2.92	znewcar1	10/17/2024 11:57:19 AM
3	GRVI 23% v9,2M c7.64 f15,7M	znewcar1	10/19/2021 6:06:39 PM
2	GRVI 39% v118M c6.98 f15,7M gapNgo to HOD9.36	znewcar1	10/14/2021 5:16:04 PM
1	GRVI 22% v5,3M c6.80 f14,5M	znewcar1	08/18/2021 10:29:20 PM

Recent Articles

• Hisense Integrates Google Home APIs for Smart Home Expansion
• Shareholder Meeting Announcement: EVS Expands Communication Efforts
• Mowi ASA Announces Ex-Dividend of NOK 1.70 to Shareholders
• Aurio Launches Finance Operations to Empower Business Growth
• Nona Biosciences Collaborates with Pfizer to Advance MesoC2
• Antengene Unveils Promising Data on Groundbreaking Cancer Treatments
• SUNMI Launches Innovative Store Concept in Atlanta's Hub
• Chenbro Displays Innovative AI Server Solutions at Key Event
• Laurent-Perrier Reveals Financial Results for 2024-2025
• Volvo Trucks Driver Challenge: Inspiring Sustainable Driving
• ProCap Acquisition Corp Completes $250 Million IPO Successfully
• FDA Approves IND for Innovative Cancer Treatment AVZO-1418
• Global Recognition for Deqing's Aquaculture Legacy in Farming
• Unveiling Global Impressions: China's Infrastructure Story
• Exploring the Future of Self-Driving Cars Industry by 2032
• Brompton Split Banc Corp. Unveils Renewed Equity Program
• Think Together Names Matt Scharpnick as Chief Innovation Officer
• Algernon Pharmaceuticals Secures Acquisition of NoBrainer Imaging
• Gyre Therapeutics Sets Public Offering at $20 Million for Growth
• Exciting Clinical Insights on Ascentage Pharma's Lisaftoclax
• Investigation Launched into Ibotta, Inc. Shareholder Concerns
• Hidrovias International Finance Unlocks Tender Offer Success
• Transforming Aging: Innovations from the Canton Fair
• ZEBRA Unveils New Non-Toxic Lip Gloss for Beauty Enthusiasts
• Exciting HUTCHMED Clinical Advances Highlighted at ASCO 2025
• CARsgen's Innovative Satri-cel Gains Recognition at ASCO
• GNTbm Enhances Cancer Immunotherapy with GNTbm-38's Advancements
• E7386's Promising Role in Combination Therapy for Cancer
• Exploring Legal Options for Viatris Investors Amid Concerns
• AI-Media and Lightning International Redefine Global Entertainment
• Revolutionizing Healthcare: MindHYVE.ai™ Partners for AI Diagnostic Leap
• Reeflex Solutions Inc. Completes Milestone Transaction Successfully
• Exploring Pixalate's Q1 2025 Ad Viewability Standards Across APAC
• Swiss Water Decaffeinated Coffee Unveils AGM Voting Outcomes
• Imperial Metals Reports Successful Director Elections Outcome
• NEDHSA's Groundbreaking Research in Integrated Care Models
• Rakuten Medical Expands Global Enrollment for Clinical Trials
• Frontera Energy Corporation Celebrates Shareholder Votes
• Dubai's Culinary Scene Thrives with Two Restaurants Winning Big
• Mullen Group Ltd. Secures Major Funding through Notes Offering
• Bunker Hill Mining Corp. Secures Funding Through Note Increase
• Jack Henry's CEO Greg Adelson Highlights Business Strategy
• Discover the Best New Online Casinos in the U.S for 2025
• The Coastal Companies Voluntary Recall of Potentially Contaminated Foods
• Exciting Developments at Vortex Energy Corp. Through LIFE Financing
• Florida Workers at UNFI Unite with Teamsters for Change
• Compass Diversified Holdings Faces Class Action Opportunity
• Prairie Provident Resources Highlights AGM Success and Future Plans
• Understanding Distribution Sources for Cohen & Steers RQI Fund
• Cohen & Steers Fund Distribution Sources and Performance Insights